Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_4

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

4(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Other(2)

Detailed Status

Completed3

unknown2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 44 (100.0%)

Trials by Status

unknown233%

completed350%

withdrawn117%

Recent Activity

0 active trials

Showing 5 of 6

completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

NCT01255722

unknownphase_4

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

NCT01580046

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07391787

Low-acid Contrast Media for Preventing Post ERCP Pancreatitis

Completed

NCT03631771Phase 4

Pediatric Risk of Hypothyroidism With Iodinated Contrast Media

Withdrawn

NCT01703650

Role of Perfusion CT in Pancreatic Cancer

Unknown

NCT01255722Phase 4

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Completed

NCT01580046Phase 4

Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

Unknown

NCT00827788Phase 4

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6